NCT01114763|Completed
Hämeenlinna Metabolic Syndrome Research Program: Oxidized LDL and Arterial Elasticity in Metabolic Syndrome and Controls (HMS-01)
HMS-01
Loading search results
HMS-01
Sponsor study identifier
observational
80
1 country
2
Study Start
June 2003
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
November 2005
Actual (reported)Study Completion
September 2007
Actual (reported)Mechanisms that link metabolic syndrome to atherosclerosis are incompletely understood. As a part of Hämeenlinna Metabolic Syndrome Research Program (HMS), 40 men with metabolic syndrome and their 40 physically active controls (age: 30 to 65 years) are compared in a cross-sectional study. Except routine laboratory parameters, arterial elasticity and levels of oxidized LDL are determined. Study hypothesis: Levels of oxidized LDL and findings in arterial elasticity may differ between subjects with metabolic syndrome and controls explaining the elevated risk for cardiovascular diseases among patients with metabolic syndrome.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 2007
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 2003
Date type not reportedThis date has not been verified as actual or estimated.
November 2005
Actual (reported)September 2007
Actual (reported)April 30, 2010
Actual (reported)May 3, 2010
Actual (reported)40 men with metabolic syndrome
40 physically active men
Primary care clinic.
Linnan Klinikka
Hämeenlinna, 13100, Finland
Central Hospital of Kanta-Häme
Hämeenlinna, 13530, Finland
Pohjantahti-Maaroos H, Palomaki A, Kankkunen P, Laitinen R, Husgafvel S, Oksanen K. Circulating oxidized low-density lipoproteins and arterial elasticity: comparison between men with metabolic syndrome and physically active counterparts. Cardiovasc Diabetol. 2010 Aug 20;9:41. doi: 10.1186/1475-2840-9-41.
serum, EDTA plasma, citrate plasma
Ari K Palomäki, MD PhD
Central Hospital of Kanta-Häme
Kalevi Oksanen, MD PhD
Central Hospital of Kanta-Häme
80 participants (actual enrollment reported by the registry).
First Submitted
April 30, 2010
First Posted
May 3, 2010
Study Start
June 2003
Date type not reportedThis date has not been verified as actual or estimated.
Study of TNF-Antagonism in Metabolic Syndrome
Contact the study team to confirm eligibility.
Primary Completion
November 2005
Actual (reported)Study Completion
September 2007
Actual (reported)Last Updated
May 4, 2010
Record last verified: 2010-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: